Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-008211
Filing Date
2020-07-10
Accepted
2020-07-10 17:46:15
Documents
1
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3902
  Complete submission text file 0001179110-20-008211.txt   5401
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address
Woodman Richard Charles (Reporting) CIK: 0001758427 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 201023931